A Comparative Cross-Platform Analysis to Identify Potential Biomarker Genes for Evaluation of Teratozoospermia and Azoospermia

Genes (Basel). 2022 Sep 25;13(10):1721. doi: 10.3390/genes13101721.

Abstract

Male infertility is a global public health concern. Teratozoospermia is a qualitative anomaly of spermatozoa morphology, contributing significantly to male infertility, whereas azoospermia is the complete absence of spermatozoa in the ejaculate. Thus, there is a serious need for unveiling the common origin and/or connection between both of these diseases, if any. This study aims to identify common potential biomarker genes of these two diseases via an in silico approach using a meta-analysis of microarray data. In this study, a differential expression analysis of genes was performed on four publicly available RNA microarray datasets, two each from teratozoospermia (GSE6872 and GSE6967) and azoospermia (GSE145467 and GSE25518). From the analysis, 118 DEGs were found to be common to teratozoospermia and azoospermia, and, interestingly, sperm autoantigenic protein 17 (SPA17) was found to possess the highest fold change value among all the DEGs (9.471), while coiled-coil domain-containing 90B (CCDC90B) and coiled-coil domain-containing 91 (CCDC91) genes were found to be common among three of analyses, i.e., Network Analyst, ExAtlas, and GEO2R. This observation indicates that SPA17, CCDC90B, and CCDC91 genes might have significant roles to play as potential biomarkers for teratozoospermia and azoospermia. Thus, our study opens a new window of research in this area and can provide an important theoretical basis for the diagnosis and treatment of both these diseases.

Keywords: CCDC90B; CCDC91; SPA17; azoospermia; biomarker genes; male infertility; teratozoospermia.

Publication types

  • Meta-Analysis

MeSH terms

  • Azoospermia* / diagnosis
  • Azoospermia* / genetics
  • Biomarkers
  • Humans
  • Infertility, Male* / genetics
  • Male
  • RNA
  • Semen / metabolism
  • Teratozoospermia* / genetics
  • Teratozoospermia* / metabolism

Substances

  • Biomarkers
  • RNA

Grants and funding

This research received no external funding.